XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
OPERATING ACTIVITIES      
(Loss) profit for the year $ (3,908,904) $ (3,820,622) $ 4,236,628
Adjustments to reconcile profit to net cash flows      
Income tax 17,972,534 14,351,170 2,206,710
Financial results 25,806,296 27,852,340 32,702,642
Depreciation of property, plant and equipment 3,769,005 3,048,539 2,010,136
Amortization of intangible assets 4,161,392 2,388,982 2,149,534
Depreciation of leased assets 1,257,538 827,320 573,897
Transactional expenses 971,539 2,022,918  
Share-based incentive and stock options 1,430,745 1,655,135 3,428,029
Share of profit or loss of joint ventures and associates (1,144,418) (997,429) (2,477,193)
Provisions for contingencies 292,732 158,818 200,525
Allowance for impairment of trade debtors 1,598,042 560,931 1,499,298
Allowance for obsolescence 849,641 579,832 977,817
Initial recognition and changes in the fair value of biological assets (6,388,030) (2,826,255) (716,741)
Changes in the net realizable value of agricultural products after harvest 42,523    
Gain or loss on sale of equipment and intangible assets (1,944,308) 733,042 297,289
Working capital adjustments      
Trade receivables (24,971,064) 1,986,982 (21,740,661)
Other receivables (7,298,822) (8,330,278) (4,864,670)
Income and minimum presumed income taxes payable 6,469,983 5,814,425 1,207,046
Inventories and biological assets (55,311,365) (34,503,283) (5,305,792)
Trade and other payables 53,477,330 (5,831,743) 8,267,538
Employee benefits and social security 3,003,793 (693,125) (477,872)
Deferred revenue and advances from customers (373,584) 2,412,315 843,981
Income and minimum presumed income taxes paid (7,059,177) (1,837,775)  
Government grants (784) (2,821) (6,603)
Interest collected 5,628,962 2,979,889 1,027,132
Inflation effects on working capital adjustments (35,846,973) (14,735,250) (16,720,191)
Net cash flows (used) generated by operating activities (17,515,374) (6,205,943) 9,318,479
INVESTMENT ACTIVITIES      
Proceeds from sale of property, plant and equipment 2,046,771 309,810 51,151
Investment in joint ventures and associates   (101,883)  
Net cash received from business combination   355,804  
Net loans granted to shareholders and other related parties (421,691)    
Proceeds from financial assets 12,331,390 9,324,335 5,041
Investment in financial assets (2,055,878) (4,275,099) (3,357,407)
Purchase of property, plant and equipment (3,458,790) (2,805,825) (1,646,697)
Capitalized development expenditures (5,149,684) (3,906,630) (1,263,730)
Purchase of intangible assets (389,039) (7,210,630) (1,591,749)
Net cash flows generated (used in) by investing activities 2,903,079 (8,310,118) (7,803,391)
FINANCING ACTIVITIES      
Proceeds from borrowings 140,431,184 143,499,367 135,348,502
Repayment of borrowings, financed payments and interest payments (123,635,106) (126,023,777) (101,317,621)
Decrease in bank overdrafts and other short-term borrowings (32,838) (3,442,491) (2,331,974)
Other financial proceeds or payments, net (180,538) (1,415,034) 2,298,360
Acquisition of non-controlling interest in subsidiaries (724,429)    
Leased assets payments (1,034,764) (728,964) (433,947)
Warrants tender offer payments   (1,030,952)  
Purchase of own shares   (3,500,020) (30,906)
Net cash flows generated by financing activities 14,823,509 7,358,129 33,532,414
Net increase (decrease) in cash and cash equivalents 211,214 (7,157,932) 35,047,502
Inflation effects on cash and cash equivalents (9,624,750) (5,584,156) (552,459)
Cash and cash equivalents as of beginning of the year 36,046,113 42,522,861 3,450,873
Effect of exchange rate changes on cash and equivalents 6,842,689 6,265,340 4,576,945
Cash and cash equivalents as of the end of the year $ 33,475,266 $ 36,046,113 $ 42,522,861